CoChat
Sign Up
Cited by 225Gastrointestinal motility and disordersInfant Health and DevelopmentGut microbiota and health

The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.

An Evidence-Based Systematic Review on the Management of Irritable Bowel Syndrome

Brandt, Lawrence J., Chey, William D., Foxx-Orenstein, Amy E., Quigley, Eamonn M.M., Schiller, Lawrence R., Schoenfeld, Philip S., Spiegel, Brennan M., Talley, Nicholas J., Moayyedi, Paul·2009·American Journal of Gastroenterology
DOI 10.14309/00000434-200901001-00002
Open this paper in CoChat — free account

Abstract

Section 2.1 Methodology for systematic reviews of irritable bowel syndrome therapy, levels of evidence, and grading of recommendations We have conducted a series of systematic reviews on the diagnostic criteria, the value of diagnostic tests, and the efficacy of therapy in IBS. We also performed a narrative review of the epidemiology of IBS. There have been several systematic reviews of therapy for IBS (1-5), but these either have not quantitatively combined the data into meta-analyses (1-3) or have inaccuracies in applying eligibility criteria and data extraction (4,5). We have, therefore, repeated all systematic reviews of IBS and synthesized the data where appropriate. Systematic review methodology For all reviews, we evaluated manuscripts that studied adults using any definition of IBS. This included a clinician-defined diagnosis, Manning criteria (6), the Kruis score (7), or Rome I (8), II (9), or III (10) criteria. For reviews of diagnostic tests, we included case series and case-control studies that evaluated serologic tests for celiac sprue (anti-gliadin, anti-endomysial, and tissue transglutaminase antibodies), lactose hydrogen breath tests, and tests for small bowel bacterial overgrowth (lactulose and glucose hydrogen breath test or jejunal aspirates). For reviews of therapies of IBS, we included only parallel group RCTs comparing active intervention with either placebo or no therapy. The following treatments were considered: Diet Fiber, bulking agents, and laxatives Antispasmodics and Peppermint Oil Antidiarrheal agents Antibiotic therapy Probiotic therapy 5HT3 antagonists 5HT4 agonists Selective C-2 chloride channel activators (Lubiprostone) Antidepressants Psychological therapies Herbal therapies and acupuncture Emerging therapies Subjects needed to be followed up for at least one week. The trial needed to include one or more of the following outcome measures: Global assessment of IBS cure or improvement Abdominal pain cure or improvement Global IBS symptom or abdominal pain scores Search strategy for identification of studies Medline (1966-June 2008), Embase (1988-June 2008), and the Cochrane Controlled Trials Register (Issue 2, 2008) electronic databases were searched. An example of the Medline search is given below. IBS patients were identified with the terms irritable bowel syndrome and functional diseases, colon (both as medical subject heading (MeSH) and free text terms), and IBS, spastic colon, irritable colon, and functional adj5 (adj5 is a term used by Medline for words that appear within 5 adjectives of each other) bowel (as free text terms). Studies identified from this search were combined with the following terms used to identify therapies for IBS: dietary fiber, cereals, psyllium, sterculia, karaya gum, parasympatholytics, scopolamine, trimebutine, muscarinic antagonists, and the following free text terms: bulking agent, psyllium fiber, fiber, husk, bran, ispaghula, wheat bran, spasmolytics, spasmolytic agents, antispasmodics, mebeverine, alverine, pinaverium bromide, otilonium bromide, cimetropium bromide, hyoscine butyl bromide, butylscopolamine, peppermint oil, loperamide and colpermin, serotonin antagonists, serotonin agonists, cisapride, receptors (serotonin, 5-HT3), and receptors (serotonin, 5-HT4; both as MeSH terms and free text terms), and the following free text terms: 5-HT3, 5-HT4, alosetron, cilansetron, tegaserod, and renzapride, psychotropic drugs, antidepressive agents, antidepressive agents (tricyclic), desipramine, imipramine, trimipramine, doxepin, dothiepin, nortriptyline, amitriptyline, selective serotonin re-uptake inhibitors, paroxetine, sertraline, fluoxetine, citalopram, venlafaxine, cognitive therapy, psychotherapy, behaviour therapy, relaxation techniques, and hypnosis (both as MeSH terms and free text terms), and the following free text terms: behavioral therapy, relaxation therapy, and hypnotherapy. Saccharomyces, Lactobacillus, Bifidobacterium, Escherichia coli or probiotics (MeSH and free text terms). An RCT filter was applied to the electronic searches. The searches were limited to humans. A recursive search of the bibliography of relevant articles also was conducted. DDW abstract books were hand searched between 2000 and 2008; UEGW abstract books were hand searched between 2000 and 2007. Authors of trial reports that did not give enough detail for adequate data extraction were contacted and asked to contribute full datasets. Experts in the field were contacted for leads on unpublished studies and no language restrictions were applied. Trials were assessed for risk of bias according to three characteristics: method of randomization, method of concealment of treatment allocation, and implementation of masking. In addition the of studies were according to the with a score of a and outcome data were by the and by a on was by using a were as and were to be treatment any improvement of IBS as a outcome was as the outcome this was not improvement in abdomi

Overview

Integrity signals

Registry

Crossref · 10.14309/00000434-200901001-00002

Cites

218 of 218 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 49

  1. Drossman, 1990, Gastroenterol Intl, 3, 159
  2. Saito, 2002, Am J Gastroenterol, 97, 1910
  3. 2002, Am J Gastroenterol, 97, S1
  4. Naliboff, 1998, Eur J Surg Suppl, 583, 57
  5. Spiegel, 2006, Gastroenterology, 130, A773
  6. Dean, 2005, Am J Manag Care, 11, S17
  7. Spiegel, 2008, Gastroenterology, 134, AB157
  8. Manning, 1978, Br Med J, 277, 653, 10.1136/bmj.2.6138.653 · DOI
  9. Kruis, 1984, Gastroenterology, 87, 1, 10.1016/0016-5085(84)90119-7 · DOI
  10. Rao, 1993, J Assoc Physicians India, 41, 357
  11. Dogan, 1996, Acta Gastroenterol Belg, 59, 225
  12. Tolliver, 1994, Am J Gastroenterol, 89, 176
  13. Banerjee, 2005, Indian J Gastroenterol, 24, 164
  14. Francis, 1996, Am J Gastroenterol, 91, 1348
  15. Agreus, 2000, Scand J Gastroenterol, 18, 105
  16. McCallum, 2005, Gastroenterology, 128, A460
  17. Zwetchkenbaum, 1988, Ann Allergy, 61, 47
  18. Petitpierre, 1985, Ann Allergy, 54, 538
  19. Arthurs, 1983, Ir Med J, 76, 253
  20. Nigam, 1984, J Assoc Physicians India, 32, 1041
  21. Schafer, 1990, Fortschr Med, 108, 488
  22. Centonze, 1988, Am J Gastroenterol, 83, 1262
  23. Ghidini, 1986, Curr Ther Res Clin Exp, 39, 541
  24. Fielding, 1980, Ir Med J, 73, 377
  25. Levy, 1977, Sem Hop Ther, 53, 372
  26. DArienzo, 1980, Rass Int Clin Ter, 60, 649
  27. Virat, 1987, Prat Med, 43, 32
  28. Baldi, 1983, Clin Trials J, 20, 77
  29. Castiglione, 1991, Ital J Gastroenterol, 23, 53
  30. Delmont, 1981, Med Chir Dig, 10, 365
  31. Pulpeiro, 2000, Prensa Med Argent, 87, 299
  32. Lech, 1988, Ugeskr Laeger, 150, 2388
  33. Capanni, 2005, Gazz Med Ital, 164, 119
  34. Pimentel, 2006, Gastroenterology, 130, A134
  35. Pimentel, 2003, Am J Gastroenterol, 98, 412
  36. Nayak, 1997, Indian J Gastroenterol, 16, 137
  37. Halpern, 1996, Am J Gastroenterol, 91, 1579
  38. Kim, 2006, Korean J Gastroenterol, 47, 413
  39. Long, 2006, Zhongguo Zhen Jiu, 26, 403
  40. Chey, 2008, Gastroenterology, 134, A401
  41. Ueno, 2005, Neurogastroenterol Motil, 17, 626
  42. Sprenger, 2007, Gastroenterology, 132, A325
  43. Rivera, 2007, Gastroenterology, 132, A191
  44. Boerner, 1988, Therapiewoche, 38, 201
  45. Vij, 1991, Indian J Psychiatry, 33, 243
  46. Bergmann, 1991, Z Klin Med, 46, 1621
  47. van der Veek, 2007, Aliment Pharmacol Ther, 26, 943, 10.1111/j.1365-2036.2007.03437.x · DOI
  48. Shaw, 1991, Digestion, 50, 36, 10.1159/000200738 · DOI
  49. Yadav, 1989, Indian J Med Res, 90, 496

Cited by

Sorted by citations

See all 225

Related

See all

Metadata

Authors
Brandt, L. J., Chey, W. D., Foxx-Orenstein, A. E., Quigley, E. M. M., Schiller, L. R., Schoenfeld, P. S., Spiegel, B. M., Talley, N. J., & Moayyedi, P.
Affiliations
  • Montefiore Medical Center (US)
  • Michigan Medicine (US)
  • Cork University Hospital (IE)
  • Baylor University Medical Center (US)
  • VA Ann Arbor Healthcare System (US)
  • University of California, Los Angeles (US)
  • Mayo Clinic (US)
  • McMaster University Medical Centre (CA)
Corresponding author
Brandt, Lawrence J.
ORCID
Venue
American Journal of Gastroenterology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2009-01
Volume
104
Pages
S8-S35
ISSN
0002-9270 (ISSN-L)
DOI
10.14309/00000434-200901001-00002
OpenAlex
W2978149037
Semantic Scholar
0791e96d7a99add0b68d1353721c81d948b6c595
Cited by
225
References
218
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 8 · 2021: 3 · 2020: 13 · 2019: 6 · 2018: 10 · 2017: 65 · 2016: 9 · 2015: 10 · 2014: 13 · 2013: 12 · 2012: 20
FWCI
3.48
Type
journal article
Language
en
Open access
closed
Locations
The American Journal of Gastroenterology (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
irritable bowel syndrome, IBS management, dietary fiber, bulking agents, laxatives, antispasmodic agents, peppermint oil, probiotics, 5-HT3 receptor antagonists, 5-HT4 receptor agonist, lubiprostone, antidepressants, psychotherapy, herbal medicine, acupuncture, small intestinal bacterial overgrowth, lactose intolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review